2014 Product Catalogue

2014 Product Catalogue
www.rcpaqap.com.au
Contents
RCPA Quality Assurance Programs Pty Ltd ...... 2

Company accreditation........................................... 2 Company structure ................................................. 2 Privacy policy ......................................................... 3
2014 Programs ..................................................... 35 Quality Assurance Programs................................. 35
INFECTIOUS DISEASES & IMMUNOLOGY GROUP .......................................................... 42

Microbiology Discipline ........................................ 42 Quality Assurance Programs................................. 42
ENROLMENT OFFICE ........................................ 4

Overview ................................................................ 4 Enrolment period ................................................... 4 Online enrolment via myQAP ................................. 4 Payment ................................................................. 4 Terms of Trade ....................................................... 5 Refund policy ......................................................... 6 Enrolment office contact details ............................. 6

Serology Discipline ............................................... 46 Quality Assurance Programs................................. 46

Synovial Fluid Discipline ....................................... 51 Quality Assurance Programs................................. 51
CHEMICAL PATHOLOGY GROUP ...................... 7

Chemical Pathology Discipline ................................ 7 Enrolment .............................................................. 7 2014 Programs ....................................................... 8 Quality Assurance Programs ................................... 9
TISSUE & CELLULAR PATHOLOGY GROUP ..... 52

Anatomical Pathology DisciplineError! Bookmark not defined. Diagnostic Profiency ProgramsError! Bookmark not defined.
HAEMATOLOGY & TRANSFUSION GROUP ..... 24

Haematology Discipline ........................................ 24 Quality Assurance Programs ................................. 24
TISSUE & CELLULAR PATHOLOGY GROUP ..... 57

Cytopathology Discipline ...................................... 57 Quality Assurance Programs................................. 57
HAEMATOLOGY & TRANSFUSION GROUP ..... 31

Transfusion Discipline........................................... 31 Quality Assurance Programs ................................. 31
MOLECULAR UNIT ......................................... 58

Molecular Genetics Program ................................ 58 Molecular Diagnostics Program............................ 60
INFECTIOUS DISEASES & IMMUNOLOGY GROUP........................................................... 33

Biosecurity Discipline............................................ 33 2014 Programs ..................................................... 33 Quality Assurance Programs ................................. 34
VIRTUAL MICROSCOPY UNIT......................... 61 NON-ANALYTICAL PROGRAMS UNIT............. 62

Key Incident Monitoring & ................................... 62 Management Systems (KIMMS) ........................... 62 Quality Assurance Programs................................. 62 Data collection ..................................................... 62 Qualified privilege ................................................ 62
INFECTIOUS DISEASES & IMMUNOLOGY GROUP........................................................... 35

Immunology Discipline ......................................... 35
POINT-OF-CARE TESTING .............................. 63

Quality Assurance Programs................................. 64
1|P ag e
RCPA Quality Assurance Programs Pty Ltd

RCPA Quality Assurance Programs Pty Ltd (RCPAQAP) was formed in 1988 by the Royal College of Pathologists of Australasia (RCPA) and has evolved to become one of the worlds leading external quality assurance (EQA) providers to pathology laboratories in Australia and globally. Programs are provided for all disciplines of pathology. All Programs have been developed with assistance from a number of professional bodies and with significant input from participating laboratories. In line with our companys philosophy all Programs are intended to continually improve the practice and standards of pathology services and health of patients.
Company accreditation
The company overall is accredited to AS/NZS ISO 9001:2008-Quality Management Systems. NATA Accredited Proficiency Testing Scheme Provider Number: 14863 Accredited for compliance with ISO/IEC 17043:2010
Company structure
Discipline-related Programs are clustered into business groups consisting of individual business units, each representing a pathology discipline or Program. The Groups are: Chemical Pathology Group Haematology & Transfusion Group Infectious Diseases & Immunology Group Tissue and Cellular Pathology Group Molecular Unit Non-Analytical Programs Unit Virtual Microscopy Unit Chemical Pathology Haematology & Transfusion Biosecurity, Immunology, Microbiology, Serology & Synovial Fluid Anatomical Pathology & Cytopathology Molecular Genetics & Molecular Diagnostics (Haematology) KIMMS
2|P ag e
Privacy policy
RCPAQAP respects the rights of individuals to privacy and the confidentiality of information about individuals it deals with. RCPAQAP is bound by the National Privacy Principles ("Principles") contained in the Privacy Amendment Act 2000 ("Privacy Act"). The Principles are designed to protect the confidentiality of personal information and the privacy of individuals by regulating the way personal information is managed. Information gathered in the course of RCPAQAP administered programs, which identifies the laboratory participating in those programs (Identifying Information), is strictly confidential, except as detailed below. RCPAQAP keeps all participant details confidential. Such details will not be disclosed to a third party, unless required by legislation, without the prior written consent of the participant. In the course of administering its programs, Identifying Information is only made available to the employees of the specific discipline Program, except where written permission for its release to a third party has been sought and given by a participant laboratory. In addition, where RCPAQAP administers programs in co-operation with the Federal government, RCPAQAP may be required by the Federal government, its delegates or employees to release Identifying Information to NATA. Further information on our Privacy Policy can be found at: www.rcpaqap.com.au
3|P ag e
ENROLMENT OFFICE
Overview
The Enrolment Office provides a single point of contact for all enrolment enquiries. Enrolments must be completed online using myQAP. For any enquiries or issues with myQAP, please contact the Enrolment Office.
Enrolment period
Programs offered by the RCPAQAP are organised over a calendar year from January to December. Whilst the key time for participants to enrol is September to December of the preceding year, the majority of RCPAQAPs will offer enrolment throughout the year depending on sample availability and dispatch dates.
Online enrolment via myQAP

Participants must enrol via myQAP for the 2014 subscription, please visit www.rcpaqap.com.au to access myQAP. Hard copy enrolment forms will not be available for 2014 enrolments onwards.
Payment
On completion of enrolment via myQAP, a Tax Invoice is generated and participants are then provided the option to: Pay by BPAY Pay by Electronic Transfer of Funds (EFT) Purchase Order Payment may be made immediately online via BPAY (Australia only) or credit card (worldwide) by clicking on the Pay Now option in the myInvoice tab in the customer portal. If a participant does not wish to pay online, payment may be made via EFT (Electronic Funds Transfer) or cheque Notice: When paying by EFT or cheque, remittance advice must be supplied before payment can be processed If participants have a PO number available before generating an invoice, the PO number can be entered into myQAP when checking out. If a tax invoice is generated before a PO number can be referenced, please contact your accounts payable department.
4|P ag e
Terms of Trade
Payment should be received within 30 days of issue of an Invoice. Failure to pay within these terms will result in the cessation of delivery of material and reports to the participant. WHEN PAYING BY EFT Company Name: RCPA Quality Assurance Programs Pty Limited Account Name: RCPA Quality Assurance Programs Pty Limited- Enrolment Account Bank: Westpac Bank Branch: Sydney BSB No: 032-000 Swift code: WPAC AU2S Account No: 186614 WHEN PAYING BY CHEQUE Please make cheques payable to RCPA QUALITY ASSURANCE PROGRAMS PTY LTD and return together with the remittance advice to: Enrolment Office RCPA Quality Assurance Programs Pty Ltd Suite 201, Level 2, 8 Herbert Street St Leonards NSW 2065 AUSTRALIA TELEPHONE AND INTERNET BANKING - BPAY Contact your bank or financial institution to make this payment from your cheque, savings, debit, credit card or transaction account. More info: www.bpay.com.au
5|P ag e
WHEN PAYING BY CREDIT CARD Please indicate for prompt processing. Credit Card: (Amex not accepted) __Visa __Mastercard Card No: _______ _______ _______ _______ Expiry Date.................................................. Cardholder's Name....................................................... Cardholder's Signature.................................................. To avoid a delay in the processing of your payment and to ensure the allocation of payment to the correct invoice please forward your remittance advice to enrolment@rcpaqap.com.au
Refund policy
Full refunds will be issued to participants if the Enrolment Office is notified of the request to withdraw prior to the supply of services from the RCPAQAP. If any materials or paperwork have been dispatched to the participant, then the refund will be reduced, or not applicable, and these policies are discipline specific. Refunds for withdrawals will not be applicable after 30th June 2014.
Enrolment office contact details

Suite 201, Level 2, 8 Herbert Street St Leonards NSW 2065 AUSTRALIA email: enrolment@rcpaqap.com.au Australia phone: 1300 78 29 20 fax: 1300 78 29 21 International phone: +61 2 9045 6000 fax: +61 2 9356 2003
6|P ag e
CHEMICAL PATHOLOGY GROUP

Chemical Pathology Discipline
The RCPAQAP Chemical Pathology is run in association with the Australasian Association of Clinical Biochemists (AACB) whose members provide expertise and assistance in many specialised working parties, setting target values, providing expert opinion for reports and collecting and preparing quality assurance material. Please consult the RCPAQAP website for more detailed information on this program. http://www.rcpaqap.com.au/chempath
Enrolment
Program prices are listed in the RCPAQAP myQAP online enrolment customer portal.
Full Program the standard enrolment

The Full Program is made up of two components: Data Management - Includes result entry, data management, Interim, End-of-Cycle and KPI reports and supplied paperwork. A Participant Handbook and Schedule are supplied. Material - a set of material containing all the samples to be analysed for the full year. The material is lyophilised unless indicated otherwise. Only one method code is permitted per analyte. If a participant wishes to report more than one per analyte, a new Participant Number is required and an additional Data Management enrolment may be purchased. Log a request on the RCPAQAP myQAP online enrolment customer portal, or contact the Enrolment Office to set up a new Participant Number.
Data Management Only

Purchasing a Data Management enrolment is useful when the material from the Full Program can be shared with a second instrument or a satellite/branch laboratory. Note: a Participant Number may have either a Full Program OR a Data Management enrolment, not both.
Modules
Previously some programs had multiple modules e.g. Blood Gases and Co-oximetry could be purchased as Blood Gases only, Co-oximetry only, or the combined module Blood Gases and Co-oximetry. In 2014 each of these modules will only be available separately.
Options
Additional material - laboratories may purchase an additional set of materials if the volume supplied in each vial is insufficient for the number of analytes the laboratory will test.
7|P ag e
2014 Programs
New Programs Endocrine <10 Analytes General Urine Chemistry <5 Analytes PoCT Blood Gases Changes in Programs Programs with multiple modules Each module only offered individually For all Abbott i-STAT and Alere epoc devices
Basic Urine Chemistry
Renamed General Urine Chemistry
General Serum Chemistry
Total T3 no longer available Special Therapeutic Drugs and Antibiotics offered as one program Creatinine added Albumin, ALP, Amylase, Total Bilirubin, Conjugated Bilirubin, GGT, Magnesium, LD, Protein, Urate added. Anion Gap, Corrected Calcium, eGFR, Osmolar Gap added. Lithium, Magnesium, Thallium, Vanadium added. Iron, Magnesium added Cobalt, Chromium, Thallium added
Special Drugs
Urine Toxicology
PoCT Chemistry
Liquid Serum Chemistry Trace Elements Serum Trace Elements Urine Trace Elements Blood
8|P ag e
Quality Assurance Programs Alcohol / Ammonia Program

Analytes Samples /Survey Surveys / Year Sample Type
Alcohol Ammonia
12
Serum
Bile Acids Program

Analytes Samples /Survey Surveys /Year Sample Type
Total Bile Acids
12
Serum
Blood Gases Program

Analytes include Samples /Survey Surveys /Year Sample Type
pH pCO2 pO2 Sodium
Potassium Chloride Glucose Lactate
Ionised Calcium Urea Creatinine 2 12 Aqueous
Note: Abbott i-STAT and Alere epoc devices should enrol in the PoCT Blood Gases Program.
Co-oximetry Program
Analytes include Samples /Survey Surveys /Year Sample Type Bovine Haemoglobin
Haemoglobin Carboxyhaemoglobin
Oxyhaemoglobin Methaemoglobin
12
Note: this program is not suitable for Abbott i-STAT devices.
BNP Program
B-type Natriuretic Peptide (BNP) N-terminal Prohormone B-type Natriuretic Peptide (NT pro BNP)
12
Serum
9|P ag e
CSF Chemistry Program

Total Protein Glucose Lactate Albumin
Immunoglobulin G Xanthochromia Screen Bilirubin (absorbance, concentration & qualitative) Xanthochromia Screen Haemoglobin (absorbance & qualitative) 2 12 CSF
CSF Oligoclonal Bands

Analytes include Sample /Survey Surveys /Year Sample Type
Oligoclonal Banding (CSF) Interpretive Comment
Oligoclonal Banding (serum)
12
CSF and Matching Serum
Endocrine Program
AFP Growth Hormone PTH Aldosterone hCG SHBG Androstenedione Homocysteine Testosterone CA 125 17-Hydroxyprogesterone TSH CEA Insulin Free T3 Cortisol LH Total T3 DHEA Sulphate Oestradiol Free T4 Ferritin Oestriol (Unconjugated) Total T4 Folate Progesterone Vitamin B12 FSH Prolactin Vitamin D3 Note: A discounted pricing option is available for <10 analytes
12
Serum
Endocrine PSA Program

Total PSA
Free PSA
12
Serum
10 | P a g e
Endocrine Red Cell Folate Program

Analytes
Samples /Survey
Surveys /Year
Sample Type
Red Cell Folate
12
Whole Blood
Endocrine ACE Program

Analytes
Samples /Survey
Surveys /Year
Sample Type
Angiotensin Converting Enzyme (ACE)
12
Serum
Faecal Occult Blood Program

Analytes
Samples /survey
Surveys /Year
Sample Type
Faecal Occult Blood (qualitative) Note: Suitable for immunological methods only.
12
Human Blood
11 | P a g e
General Serum Chemistry Program

Analytes include Albumin Bicarbonate Bilirubin-Total Bilirubin-Conjugated Calcium Chloride Creatinine Fructosamine Glucose Lactate Lithium Magnesium Osmolality Phosphate (Inorganic) Potassium Protein (Total) Sodium Urate Urea Iron TIBC Transferrin Ferritin Troponin I (quantitative) Troponin T (quantitative) Troponin T (semiqualitative) Roche Cardiac Reader only Endocrine Cortisol Thyroxine Free T4 TSH Free T3 hCG (quantitative) hCG (qualitative) Enzymes ALT Alkaline Phosphatase Amylase AST Cholinesterase Creatine Kinase CK-MB GGT Lactate Dehydrogenase Lipase Phenobarbitone Phenytoin Lipids Cholesterol Triglyceride HDL Cholesterol Drugs Carbamazepine Digoxin Paracetamol Salicylate Theophylline Valproate Gentamicin Vancomycin Samples /Survey Surveys /Year Sample Type
24
Lyophilised Serum and Matching Diluent
Note 1. Discounted pricing options available for: 31 40 analytes 21 30 analytes 11 20 analytes <10 analytes Note 2. Troponin T (semi-qualitative) on Roche Instruments Participants using the Roche Cardiac Reader should enrol in the General Serum Chemistry Program. Participants with Roche cobas h232 should enrol in the PoCT Troponin Program. This is due to the different cut-offs, standardisation and units of these 2 instruments.
12 | P a g e
Glycohaemoglobin Lyophilised Program

HbA1c
12
Lyophilised blood
Glycohaemoglobin Whole Blood Program

HbA1c
Fresh Blood
IGF-1/C Peptide Program

IGF-1
C Peptide
IGF-BP3
12
Serum
13 | P a g e
Liquid Serum Chemistry Program

Analytes including Lipids, Endocrine & Enzyme Samples /Survey Surveys /Year Sample Type
Albumin Bicarbonate Bilirubin-Total BilirubinConjugated Calcium Chloride Creatinine Fructosamine Glucose Lactate Magnesium Osmolality Phosphate (Inorganic) Potassium
Protein (Total) Sodium Urate Urea Iron TIBC Transferrin Ferritin ALT Alkaline Phosphatase Amylase AST Cholinesterase Creatine Kinase
GGT Lactate Dehydrogenase Lipase Cholesterol Triglyceride HDL Cholesterol Cortisol TSH Free T4 Free T3 Anion Gap* Corrected Calcium* eGFR* Osmolar Gap* 2 1 Fresh Frozen Serum
*New analytes for 2014.
Please note this program is not offered to overseas participants.
Neonatal Bilirubin Program

Total Bilirubin
Conjugated Bilirubin
12
Serum
On-Site Urine Toxicology Screening Program

Amphetamine Methamphetamine Benzodiazepines
Cocaine metabolites Cannabis metabolites Opiates 1 12 Urine
14 | P a g e
15 | P a g e
Patient Report Comments Program

A program for commenting on patient biochemistry results. A set of patient results is provided to participants. Participants are asked to provide comments they would typically add to the report or give verbally. Ten cases are provided per year. Enrolment is for an individual person. Samples are not issued with this program.
Plasma Metanephrines Program

Metanephrine Normetanephrine 3-Methoxythyramine 2 12 Plasma
Point-of-Care Testing Blood Gases Program

pH pCO2 pO2 Urea
Sodium Potassium Chloride
Glucose Haemoglobin* Lactate
Ionised Calcium Haematocrit* Creatinine 2 12 Aqueous
* Optimised for the Abbott i-STAT and Alere epoc devices.
Point-of-Care Testing Chemistry Program

Albumin ALP ALT Amylase AST Bicarbonate Bilirubin Total
Bilirubin Conj Calcium Chloride Cholesterol CK Creatinine GGT
Glucose HDL Cholesterol Magnesium LD Phosphate Potassium Protein
Sodium Triglycerides Urate 2 12 Lyophilised Serum and Matching Diluent
Note: This program is designed specifically for PoCT instruments such as the Samsung LABGEO, Roche Reflotron, Abaxis Piccolo, Ortho Clinical Diagnostics DT60, Cholestech Dx etc.
Point-of-Care Testing Troponin Program
Abbott i-STAT are recommended to enrol in the PocT Blood Gases Program.
16 | P a g e
Analytes include
Samples /Survey
Surveys /Year
Sample Type
Troponin I Troponin T (semi-quantitative) 2 Note: Suitable for devices such as Abbott i-STAT and Roche cobas h232
12
Serum
Porphyrins Urine Program

Urine Total Porphyrin Quantitative Porphobilinogen Qualitative Porphobilinogen
Urine ALA Urine Porphyrin Components
12
Urine
Porphyrins Plasma Program

Plasma Total Porphyrin
Plasma Porphyrin Components
12
Plasma
Porphyrins Faeces Program

Faecal Dry Weight Faecal Total Porphyrin
12
Faeces
Faecal Porphyrin Components
Porphyrins Whole Blood Program

Whole Blood Total Porphyrin Whole Blood Total Porphyrin Clinical Evaluation Whole Blood Porphyrin Fractions 2 12
Whole Blood
Porphyrin Patient Report Comments

Three clinical cases are offered each year. A set of patient porphyrin results is provided to participants. Participants are asked to provide comments they would typically add to the report or give verbally. Participation is from individuals rather than a laboratory. Multiples individuals from the same laboratory can return comments. A report is generated for each individual. There is no extra charge for participation.
17 | P a g e
Special Drugs Program

Amiodarone Clozapine Methotrexate Mycophenolate
Tricyclic Antidepressants (Qualitative) Amitriptyline Nortriptyline
Amikacin Gentamicin Tobramycin Vancomycin 2 12 Serum
Immunosuppressants Program
Cyclosporin Sirolimus
Tacrolimus
12
Whole Blood
Special Lipids Program

Cholesterol HDL Cholesterol LDL Cholesterol Triglyceride
Apolipoprotein A1 Apolipoprotein B Lipoprotein (a) 2 12 Serum
Sweat Electrolytes Program

Sodium Chloride
Sweat Conductivity Clinical Evaluation
12
Aqueous
18 | P a g e
Trace Elements Serum Program

Aluminium Chromium Cobalt Copper
Lithium* Magnesium* Selenium Thallium* Vanadium* 2 12 Frozen Bovine Serum
Zinc Note: The RCPAQAP will be joining the Occupational and Environmental Laboratory Medicine Trace Elements Program (OELM) for serum, urine and blood trace elements. This is a federation of 6 countries and the advantage of this will be a much larger peer group. This program will run from April to March. Result entry will be electronic only. OELM and RCPAQAP style reports will be available. *New analytes for 2014
Trace Elements Urine Program

Arsenic Cadmium Chromium Cobalt Copper Iron Lead *New analytes for 2014
Magnesium* Manganese Mercury Nickel Selenium Thallium Vanadium Zinc 2 12 Frozen Human Urine
Trace Elements Whole Blood Program

Arsenic Cadmium Cobalt* Chromium* Lead Magnesium* *New analytes for 2014
Manganese Mercury Selenium Thallium Zinc 2 12 Frozen Human Blood
19 | P a g e
Tumour Markers Program

ACTH Alpha-fetoprotein Beta-2-Microglobulin Calcitonin CEA
CA 125 CA 15-3 CA 19-9 Gastrin hCG
NSE Total PSA Prolactin Thyroglobulin 2 12 Serum
General Urine Chemistry Program

Albumin ACR Calcium Chloride Cortisol Creatinine Free Deoxypyridinoline Glucose hCG-Qualitative
Magnesium N-Telopeptides Osmolality Phosphate Potassium Sodium Total Protein Urate Urea 2 12 Urine
hCG-Quantitative Note: A discounted pricing option is available for <5 analytes.
Biogenic Amines Program

Noradrenaline 5HIAA Adrenaline Dopamine HMMA Clinical Evaluation
HVA 3-Methoxytyramine Metanephrine Normetanephrine Serotonin 3 (2 Linear, 1 Patient) 12 Urine
20 | P a g e
Urine Pregnancy Program

hCG (qualitative)
Urine
Urine Toxicology Program

Qualitative drug Screening Creatinine* 1 12 Urine Note: 10 mLs of lyophilised sample is provided. Laboratories using non-immunoassay methodology may need to purchase additional set of material.
Vitamins Plasma Program

Vitamin A Vitamin E -carotene Total Carotenoids Plasma Vitamin B6 2 12 Plasma
Vitamins Whole Blood Program

Vitamin B1 Vitamin B2 Vitamin B6 2 12
Whole Blood
Vitamin C Program
Analytes
Samples /Survey
Surveys /Year
Sample Type
Vitamin C
12
Serum
21 | P a g e
The following programs are only available to participants outside Australia and New Zealand
Condensed Serum Chemistry Program

Analytes include Albumin Bicarbonate Bilirubin-Total Bilirubin-Conjugated Calcium Chloride Creatinine Fructosamine Glucose Lactate Lithium Magnesium Osmolality Lipids Cholesterol Triglyceride HDL Cholesterol Phosphate (Inorganic) Potassium Protein (Total) Sodium Urate Urea Iron TIBC Transferrin Ferritin Troponin I (quantitative) Troponin T (quantitative) Troponin T (semiqualitative) Roche Cardiac Reader only Endocrine Cortisol Thyroxine Free T4 TSH Total T3 Free T3 hCG (quantitative) hCG (qualitative) Enzymes ALT Alkaline Phosphatase Amylase AST Cholinesterase Creatine Kinase CK-MB GGT Lactate Dehydrogenase Lipase Drugs Carbamazepine Digoxin Paracetamol Phenobarbitone Phenytoin Salicylate Theophylline Valproate Gentamicin Vancomycin 2 24 Lyophilised Serum and Matching Diluent Samples /Survey Surveys /Year Sample Type
Note: Discounted pricing options for:
31 40 analytes 21 30 analytes 11 20 analytes <10 analytes
22 | P a g e
Basic Serum Chemistry Program

Amylase Albumin Alkaline Phosphatase ALT AST Bicarbonate
Calcium Cholesterol Creatinine Kinase Creatinine Glucose HDL Cholesterol
Protein (Total) Sodium Triglycerides Urate Urea 2 6

Lyophilised Serum and Matching Diluent
Bilirubin-Total Potassium Note: Suitable for very small laboratories doing a limited range of testing.
23 | P a g e
HAEMATOLOGY & TRANSFUSION GROUP

Haematology Discipline
Thirteen surveys are dispatched each year with a wide range of samples for both routine and specialist haematology testing. For more information on these please consult the Haematology Participant Handbook or the RCPAQAP haematology website for more details. http://www.rcpaqap.com.au/haematology/ Prices for participation are listed in the RCPAQAP myQAP online enrolment customer portal.
Quality Assurance Programs Full Blood Count Program (FBC)

Tests include Abbreviation Surveys/Year Samples/Survey Sample Type
White Blood Cells Red Blood Cells Hemoglobin Haematocrit Mean Cell Volume Platelet
WBC RBC Hb HCT MCV PLT
12
Stabilised whole blood
Haemostasis Program
Tests include Abbreviation Surveys/Year Samples/Survey Sample Type
International Normalised Ratio Activated Partial Thromboplastin Time Fibrinogen Thrombin Time
INR APTT Fib TT 8 2 Lyophilised plasma
24 | P a g e
Additional Factors Program

Tests include Abbreviation
Module 1 Factor VIII Factor IX Module 2 Factor II Factor V Factor VII Factor XI Factor XII FVIII FIX FII FV FVII FXI FXII
Surveys/ Year
Samples/ Survey
Sample Type
Lyophilised plasma
Lyophilised plasma
D-Dimer Program
Tests Abbreviation Surveys/ Year Samples/ Survey Sample Type
Module 1 D-Dimer fully quantitative Module 2 D-Dimer semi quantitative / qualitative 2 Lyophilised plasma fibrin degradation fragment 4 2 Lyophilised plasma
fibrin degradation fragment
Haemoglobinopathy Program
Tests Abbreviation Surveys/ Year Samples/ Survey Sample Type
Haemoglobin A2 Haemoglobin F Variant Haemoglobin
Hb A2 Hb F Variant 4 1
Lyophilised red cells
Morphology/Manual Differential Program

Tests Surveys/ Year Samples/ Survey Sample Type
Morphology Program Blood Film Differential Count Morphology Educational DVD Virtual Images
4 12
3 1
Blood Film Blood Film
DVD
25 | P a g e
Paediatric Morphology Virtual Microscopy Program

Tests Surveys/Year Samples/Survey Sample Type
Description & Diagnostic Interpretation of paediatric blood films
Virtual imagessupplied on DVD
Reticulocyte Program
Tests Abbreviation Surveys/Year Samples/Survey Sample Type
Reticulocyte count Program Module Module 1
Retic count Compatible Instrument/Method Manual Reticulocyte counting Beckman Coulter (STKS, MAXM, HmX) Sysmex Corporation: XT2000i, XE2100, XE5000, XT4000i, RAM-1) Abbott (Cell Dyn 3200/Ruby, 3500, 3700, 4000/Sapphire Siemens ADVIA Manual Reticulocyte counting Beckman Coulter (Gen.S, LH500, LH750, LH755 & UniCell DxH 800)
Module 2
Module 3
ESR Program
Erythrocyte Sedimentation Rate Program Module Module 1 Module 2
ESR Compatible Instrument/Method All methods excluding StaRRsed users StaRRsed users ONLY
26 | P a g e
Automated Differential Program

WBC Differential Program Module Module 1 Module 2 Module 3 Module 4 Module 5
WCC, Neut/Gran, Lymph, Mono, Eos, Baso Compatible Instrument Sysmex Corporation: XT1800i, XT2000i, XT4000i, XE2100, XE5000, XS1000i, XS800i, XN series Abbott Laboratories: Cell-Dyn 3000, 3200/Ruby, 3500, 3700, 4000/Sapphire Beckman Coulter: Act 5 Diff, ABX Pentra 60C+ Bayer Diagnostics: ADVIA 120/2120, Technicon H Systems Sysmex Corporation: K-1000, KX-21, K-4500, PocH100i NO LONGER AVAILABLE AS A MODULE Abbott Laboratories: Cell-Dyn 1200,1300,1600,1700,1800 Beckman Coulter: Act/Act Diff, T series, JT series JS,JR,ST, Onyx, MD series ABX Diagnostics: Micros 60, MINOS, ABX Argos Nihon Kohden: Celltac Bayer Diagnostics: ADVIA 60 Beckman Coulter: STKS, MaxM, HMX, LH 500/750/755/780, GENS Sysmex Corporation: SE9500, SE9000, SF3000 NO LONGER AVAILABLE AS A MODULE PLEASE NOTE - If the instrument used is not listed in the above table, please contact the RCPAQAP Haematology office for selection of the correct module.
Module 6
Module 7 Module 8
G6PD Program
Tests Abbreviation Surveys/Year Samples/ Survey Sample Type
Glucose-6-phosphate dehydrogenase Screen Glucose-6-phosphate
G6PD Screen G6PD Assay
Lyophilised haemolysate
27 | P a g e
dehydrogenase Assay
28 | P a g e
Paediatric Morphology Virtual Microscopy Program

Tests Surveys/Year Case studies / Survey Sample Type
Descriptive and Diagnostic Interpretation of paediatric blood films
Malarial Parasite Virtual Microscopy Program

Tests Surveys/Year Case studies/ Survey Sample Type
Malarial Parasite identification of thin and thick blood films.
Point-of-Care INR Program

Tests Abbreviation Surveys/Year Samples/ Survey Sample Type
International Normalised Ratio
INR
Lyophilised plasma + water + calcium
Molecular Diagnostics Program

Program Module Assays Surveys/Year Samples/ Survey Sample Type
Module 1
Module 2 Module 3 Module 4 Module 5 Module 6 Module 7 Module 8
Factor V Leiden MTHFR (Ala677Val) Prothrombin gene G20210A mutation Hereditary Haemochromatosis Cys282Tyr Hereditary Haemochromatosis His63Asp bcr-abl for CML bcr-abl for ALL T cell receptor gene Immunoglobulin heavy chain gene Chimerism Thalassaemia beta Thalassaemia alpha Jak 2 PML:RARa
DNA
2 1 1 1 1 1 1
5 5 5 5 3 5 3
DNA RNA DNA DNA DNA DNA RNA
29 | P a g e
Oncology Immunophenotyping Program

Program Module Assays Surveys /Year Samples/Survey Sample Type
Module 1
Oncology Immunophenotyping (AML, T and B cell ALL and LPDDiagnostic Interpretation) PNH Testing (not included in scope of accreditation)
1 case study
Stabilised PB/BM mononuclear cells Stabilised PB/BM mononuclear cells
Module 2
CD34+ Program
WCC %CD34 Total CD34/uL 3 2
Specialised Haemostasis Program

Program Module Assays Surveys/Year Samples/Survey Sample Type
Program A Program B Program B Program B Program B Program C Program D Program E Program F Module 1 Module 2
Lupus Anticoagulant additional dispatch in 2013 Protein C Protein S Antithrombin APC resistance von Willebrand Factor FVIII Inhibitor PFA-100 analysis Heparin Monitoring
3 2 2 2 2 2
2 2 2 2 2 2
Lyophilised plasma Lyophilised plasma Lyophilised plasma Lyophilised plasma Lyophilised plasma Lyophilised plasma
PLEASE NOTE -
Unfractionated Heparin Low Molecular Weight Heparin Laboratories enrolling in the Heparin Monitoring module must enrol in both modules if monitoring unfractionated and low molecular weight heparin.
30 | P a g e
HAEMATOLOGY & TRANSFUSION GROUP

Transfusion Discipline
The General Transfusion program covers all routine tests performed in a pre-transfusion testing laboratory including clinical decision making on given scenarios. The Individual Assessment program is designed to assist laboratory supervisors maintain and assess individual staff competencies while also enabling individual staff to meet EQA participation requirements as stipulated by the guidelines. The Foetal Maternal Haemorrhage Estimation program is for assessing laboratories on methods used in estimating foetal red cells in maternal samples. All programs are specifically arranged so laboratories of all sizes may participate. For more information on these please consult the transfusion discipline handbook or the RCPAQAP Transfusion website for more details. http://www.rcpaqap.com.au/transfusion/ Prices for participation are listed in the RCPAQAP myQAP online enrolment customer portal.
Quality Assurance Programs General Transfusion Program - (GT Program)

Modules Surveys/Year Samples/Survey Sample Type
General Compatibility (AG Module) Tests include blood grouping, antibody screen and identification, crossmatch/ compatibility testing, phenotyping, DAT, and elution studies. Basic Compatibility Module (AB module) - Includes all tests in the AG module except antibody identification, phenotyping and elution studies. Phenotyping Module (AP module) Extended Red Cell Antigen Phenotyping Antibody Titre Module (AA module) Anti-D Titre
Varied
EDTA whole blood and Red cells
Varied
EDTA whole blood and Red cells
Red cell sample
Plasma
31 | P a g e
Blood Grouping and Antibody Screen Program (B Program)

Module Surveys/Year Samples/Survey Sample Type
Blood grouping (Antibody Screen/Identification Optional)
EDTA Whole blood
Individual Assessment Program - (I Program)

Individual Assessment Program (up to 3 participants results can be submitted per survey)
EDTA Whole blood
Foetal Maternal Haemorrhage Estimation - (F Program)

Foetal Maternal Haemorrhage Estimation
EDTA Whole blood
Snake Venom Detection- (SV Program)

Module Surveys/Year Samples/Survey
Snake Venom Detection
Sample Type
Swab
Transfusion Competency Program- (ST Program)

Module includes Surveys/Year Samples/Survey
Blood Grouping Weak D testing DAT Antibody Screen Antibody identification Phenotyping (Rh/ K antigens only) Crossmatching/ Compatibility Testing
Sample Type
6 6 6 6
3 1 3 2 2 red cell donor units EDTA Whole blood
32 | P a g e
INFECTIOUS DISEASES & IMMUNOLOGY GROUP

Biosecurity Discipline
In 2008 the Australian Government established a two-tiered list of Security Sensitive Biological Agents (SSBA) as part of the SSBA Regulatory Scheme for the control of select agents. The program now offers surveys for SSBA, other potential agents and communicable disease threats to Australia with a view to building and enhancing laboratory capacity and capability to detect, analyse, identify and report on these agents. Refer to the Australian Government Department of Health and Ageing (DoHA) website for current Security Sensitive Biological Agents Lists. http://www.health.gov.au/SSBA#list All enquiries regarding the content and cost of the RCPAQAP Biosecurity program should be directed to biosecurity@rcpaqap.com.au
After consultation with the RCPAQAP Biosecurity team, enrolments for the program should be arranged through the RCPAQAP Enrolment office, enrolment@rcpaqap.com.au.
2014 Programs
New Modules
eLearning Module and Simulated Exercise Module
33 | P a g e
Quality Assurance Programs Sample Modules

Modules - Available to Australian laboratories that require the capability to test for Security Sensitive Biological Agents, other potential agents and communicable disease threats. These include Bacteria Virus & Toxins Bacterial modules Clinical or environmental analytes Derivations of vaccine strains Genetic material Inactivated material Surrogate organisms Viral modules Toxin modules Non-toxic subunits Inactivated toxins Non-toxin producing strains Genetic material In vitro RNA Transcripts Plasmids Surrogate organisms
Virtual Module
Modules - Available to all laboratories within Australia and approved international laboratories.
eLearning Module
Modules - Available to all laboratories within Australia and approved international laboratories.
Simulated Exercises in Biopreparedness

Modules - Available to selected laboratories within Australia Simulated exercises in a controlled environment to test the biopreparedness of selected laboratories. Please refer to Biosecurity Participant Handbook or the website for further details on annual survey material: http://www.rcpaqap.com.au/biosecurity/
34 | P a g e

Immunology Discipline
Participating laboratories may select from a group of RCPAQAP Immunology program modules that comprehensively cover the assays performed in Clinical Immunology. For more detailed information please refer to our website or Immunology Participant Handbook. http://www.rcpaqap.com.au/immunology/ Prices for participation are listed in the RCPAQAP myQAP online enrolment customer portal.
2014 Programs
New Programs Food Allergy Program Myositis Specific and Scleroderma Antibodies Program
Quality Assurance Programs Specific Proteins Program

Analytes include Abbreviation Samples/Survey Surveys/Year Sample Type
Immunoglobulin G Immunoglobulin A Immunoglobulin M Complement component 3 Complement component 4 -1-antitrypsin C1 esterase inhibitor Haptoglobin Caeruloplasmin Prealbumin
IgG IgA IgM C3 C4 A1AT, AAT C1-inh Hp Caeruloplasmin Transthyretin 2 12 Serum
35 | P a g e
Rheumatoid Factor Program

Analytes include Abbreviation Samples/Survey Surveys/Year Sample Type
Rheumatoid Factor Cyclic citrullinated peptide antibody
RF CCP
12
Serum
C Reactive Protein Program

Analytes include Abbreviation Samples/ Survey Surveys/Year Sample Type
C-reactive Protein High-sensitivity C-reactive protein
CRP hsCRP
12
Serum
Paraprotein Program
Analytes include Samples/ Survey Surveys/Year Sample Type
Paraprotein identification serum Paraprotein identification urine Paraprotein concentration serum Paraprotein concentration urine Serum free light chains
Serum Urine Serum Urine Serum
IgG Subclasses Program

IgG1 IgG2 IgG3 IgG4 Calculated subclass sum Total IgG
Serum
Anti-Nuclear Antibodies Program

Analytes include Abbreviation Samples /Survey Surveys /Year Sample Type
Anti-Nuclear Antibodies pattern Anti-Nuclear Antibodies titre
ANA pattern ANA titre
12
Serum
36 | P a g e
Rheumatic Disease Serology Program

Extractable Nuclear Antigen Anti-double stranded DNA Nucleosome antibodies Cardiolipin IgG and IgM antibodies 2GP1 IgG antibodies
ENA dsDNA antibodies AnuA Antiphospholipid Abs Anti 2 Glycoprotein 1 IgG Ab
1 each for ENA, DNA, phospholipid antibodies
Serum
Vasculitis Serology Program

Analytes include Abbreviation Samples /Survey Surveys/Year Sample Type
Antineutrophil Cytoplasmic Antibodies Myeloperoxidase Antibodies Proteinase 3 Antibodies Anti-glomerular basement membrane
ANCA MPO-ANCA PR3-ANCA GBM
Serum
Coeliac Serology Program

Analytes include Abbrev. Samples /Survey Surveys /Year Sample Type
Deamidated Gliadin IgG and IgA Tissue transglutaminase IgG and IgA Endomysial antibodies Skin antibodies (intercellular substance, basement membrane)
tTG EMA ICS, BMZ
Serum
37 | P a g e
Tissue Antibodies Program

Gastric Parietal Cell antibodies Smooth Muscle antibodies F-Actin antibodies Mitochondrial antibodies Liver/Kidney Microsome antibodies Intrinsic Factor antibodies Thyroglobulin antibodies Thyroid microsome antibodies Thyroid receptor antibodies
APC ASM F-actin AMA LKM IF TgAb TPO TRAb
8 Serum
Type I Diabetes Antibodies Program

Islet cell antibodies Glutamic Acid Decarboxylase antibodies Insulinoma-associated-2 autoantibodies
ICA GAD IA2 antibodies
Serum
Myasthenia Gravis Antibodies Program

Analytes Abbreviation Samples /Survey Surveys /Year Sample Type
Acetylcholine Receptor Antibodies
Myasthenia Gravis Ab; AChR
Serum
Myositis Specific and Scleroderma Antibodies Program

Myositis and scleroderma antibodies
Mi-2, Ku, RNA Pol III
Serum
IgE (Total) Program

Immunoglobulin E
IgE
12
Serum
38 | P a g e
Tryptase Program
Tryptase
Mast Cell Tryptase
Serum
Bee Venom IgE Program

Specific IgE to Bee Venom (Apis mellifera)
Serum
Food Allergy Program

Specific IgE to: Prawn Peanut Cashew Cows Milk Egg Sesame Seed Soy Wheat Grain
Serum
Inhalant Allergens Program

Cat epithelium/dander Rye grass pollen Bermuda grass House dust mite (Dermatophagoides pteronyssinus) Latex Aspergillus fumigatus Alternaria alternata/tenuis Grass Pollen mix Animal Epithelium mix Mould mix House Dust Mite mix
Serum
39 | P a g e
Fungal & Avian Antibodies Program

IgG antibodies to Aspergillus fumigatus IgG antibodies to Budgie IgG antibodies to Pigeon
Serum
HLA B27 Status Program

Human Leukocyte Antigen B27
HLA B27
Lithium Heparin Whole blood diluted with media
The material assayed in the HLA B27 program is fresh whole blood, which quickly deteriorates under normal transport conditions and should be tested within 3-4 days of dispatch. For reasons beyond our control, it may take longer than this to deliver samples to some centres outside Australia and New Zealand and in these cases we are unable to guarantee the quality of the material received or provide replacements. Please consider carefully before ordering this program and contact us if you wish to discuss your individual situation.
Immunophenotyping - Immunodeficiency Program

Lymphocytes of the following phenotypes (percentages): CD3+, CD3+CD4+, CD3+CD8+, CD19+, CD3-CD16+, CD3-CD56+, CD3-CD16+CD56+, Alpha-Beta, Gamma-Delta Lymphocytes of the following phenotypes (absolute numbers);CD3+, CD3+CD4+, CD3+CD8+, CD19+ 2 8
Lithium Heparin whole blood diluted with media
The material assayed in the Immunophenotyping program is fresh whole blood, which quickly deteriorates under normal transport conditions and should be tested within 3-4 days of despatch. For reasons beyond our control, it may take longer than this to deliver samples to some centres outside Australia and New Zealand and in these cases we are unable to guarantee the quality of the material received or provide replacements. Please consider carefully before ordering this program and contact us if you wish to discuss your individual situation.
40 | P a g e
HLA B*57 (in conjunction with APHIA) Program

Human Leukocyte Antigen B*57
HLA B*57
DNA
A program of Immunology clinical case studies. This is a paperwork program only and no samples are provided. Five clinical cases are provided per year.
Case Study Program
41 | P a g e

Microbiology Discipline
The RCPAQAP Microbiology discipline has been developed and evolved under the guidance of the RCPAQAP Microbiology Advisory Committee. For detailed information on Microbiology programs please consult the Microbiology participant handbook or the RCPAQAP microbiology website for more details. http://www.rcpaqap.com.au/microbiology Prices for participation are listed in the RCPAQAP myQAP online enrolment customer portal.
Quality Assurance Programs Bacteriology Extensive Program

Tests include Abbrev. Surveys/Year Samples/Survey Sample Type
Urine Skin/Ear/Eye/Throat/Nose Faecal Respiratory Genital Swabs/Anaerobes Mycobacteriology Difficult/Blood Culture/Sterile sites
U S F R G M D 1 8 7-8 Lyophilised samples and slides Lyophilised sample Lyophilised sample
Bacteriology Limited Program

Tests include Abbrev. Surveys/Year Samples/Survey Sample Type
Urine Skin/Ear/Eye/Throat/Nose Faecal Respiratory Genital Swabs/Anaerobes Mycobacteriology Difficult/Blood Culture/Sterile sites
U S F R G M D
4 4 4 4 4 4 8
2 2 2 2 2 2 1
Lyophilised sample Lyophilised sample Lyophilised sample Lyophilised sample Lyophilised sample Lyophilised samples and Slides Lyophilised sample
42 | P a g e
Mycology Program
Tests Include Surveys/Year Samples/Survey Sample Type
Dermatophytes, systemic mycotic pathogens, clinically significant yeast and contaminants of interest.
Lyophilised sample
Parasitology Program
Tests Include Surveys/Year Samples/Survey Sample Type
Protozoa, helminths and samples containing faecal artefacts.
Fixed smears /faecal suspensions.
Urine Dipstick Chemistry Program

Tests include Surveys/Year Samples/Survey Sample Type
Leukocyte esterase blood glucose protein nitrite
Lyophilised sample
Stat Microscopy Program

Tests include Surveys/Year Samples /Survey Sample Type
Includes urine cell counts and Gram stains of samples.
Lyophilised samples and smears
Pneumococcal Serotyping Program

Serotyping of S. pneumoniae
Lyophilised sample
43 | P a g e

Tests - Nucleic acid amplification testing (NAT) Tests include Surveys /Year Samples /Survey Sample Type
Bordetella pertussis Chlamydia trachomatis* and Neisseria gonorrhoeae** Cytomegalovirus Enterovirus Herpes simplex virus 1 and 2 MRSA mecA/nuc genes Mycobacterium tuberculosis and Mycobacterium avium complex Varicella zoster virus Neisseria meningitidis * Note - the Chlamydia trachomatis samples are not suitable for immunofluorescence or EIA assays. ** Note - the Neisseria gonorrhoeae samples are not suitable for detection by RNA methods. 2 6-8 Lyophilised sample
Vancomycin-Resistant Enterococci (VRE) Program

Tests include Surveys /Year Samples /Survey Sample Type
VRE testing including screening, phenotypic testing and/or Molecular testing.
Lyophilised simulated sample
Clostridium difficile Laboratory Diagnosis Program

Tests Surveys /Year Samples /Survey Sample Type
Testing for Clostridium difficile antigen and toxin.
Lyophilised simulated sample
44 | P a g e
Microbiological Surveillance Culture Program

Microbiological Surveillance Culture for endoscopes and bronchoscopes
Lyophilised simulated sample sample
Paperwork Only Program

This module is designed for manufacturers and sponsors (distributors) of kits. Participants enrolled in the Paperwork Only do not receive samples.
45 | P a g e

Serology Discipline
Key features of the program include; One sample dispatch per year; All methodologies accepted; Comprehensive assessment of over 50 analytes; Detection of antibodies, antigens, DNA & RNA; Direct data entry via website; Final Generic reports reviewed by experts in the field; Individualised Participant Assessment Reports available within one week of the survey due date, showing year-to-date cumulative scores and graphical analysis of results; Trend analysis with a minimum of 2 surveys/year (for most analytes); Archived survey material including the relevant reports are available for participants to purchase for validation studies
http://www.rcpaqap.com.au/serology/ Prices for participation are listed in the RCPAQAP myQAP online enrolment customer portal.
Quality Assurance Programs Antenatal Program

Modules Samples/Survey Surveys/Year Sample Type
Rubella serology Syphilis serology
2 2
4 4
Serum/Plasma Serum/Plasma
46 | P a g e
Bacterial Program
Brucella serology Chlamydia pneumoniae serology Chlamydia trachomatis Antigen EIA Chlamydia trachomatis Antigen IFA Chlamydia trachomatis Antigen NAT Helicobacter pylori serology Legionella serology Legionella Urinary Antigen Mycoplasma serology QuantiFERON -TB Gold (detection only) Rickettsial serology Streptococcal serology
2 2 2 2 2 2 2 2 2 2 2 2
2 2 2 2 2 2 2 2 2 2 2 2
Serum/Plasma Serum/Plasma Culture supernatant Slide Culture Supernatant Serum/Plasma Serum Urine Serum/Plasma Lyophilised Serum/Plasma Serum/Plasma Serum/Plasma
Hepatitis Program
Hepatitis A serology Hepatitis B serology Hepatitis C serology Hepatitis D serology Hepatitis E serology
2 2 2 2 2
6 6 6 1 1
Serum/Plasma Serum/Plasma Serum/Plasma Serum/Plasma Serum/Plasma
Infectious Mononucleosis Program

Infectious Mononucleosis
Serum/Plasma
Lymphadenopathy Program
Cytomegalovirus serology Epstein Barr Virus serology Toxoplasma serology
2 2 2
4 4 4
Serum/Plasma Serum/Plasma Serum/Plasma
47 | P a g e

Alphavirus & Flavivirus NAT Hepatitis B DNA (Qualitative/ Quantitative) Hepatitis C RNA (Qualitative/ Quantitative) Hepatitis C Genotyping HIV-1 RNA (Quantitative) Human Papillomavirus DNA Influenza *Sent on dry ice
3 3
3 4
Inactivated viral culture lysate* Plasma*
3 3 3 4 6
4 4 4 3 3
Plasma* Plasma* Plasma* PreservCyt Solution. Inactivated viral culture lysate
Point-of-Care Program
HIV PoCT ONLY Influenza A & B Antigen PoCT ONLY RSV Antigen PoCT ONLY
2 2 2
4 4 4
Whole blood or Serum/Plasma Inactivated viral culture lysate Inactivated viral culture lysate
48 | P a g e
Parasite & Spirochaete Program

Cryptococcal Antigen Entamoeba serology Hydatid serology Leptospiral serology Schistosomiasis serology
2 2 2 2 2
2 2 2 2 2
Serum or culture supernatant Serum/Plasma Serum/Plasma Serum Serum/Plasma
Retroviral Program
HIV serology (comprehensive) HTLV serology
2 2
6 6
Serum/Plasma Serum/Plasma
Vaccine Preventable Program

Bordetella pertussis serology Influenza A & B Antibody serology Measles serology Mumps serology Q fever serology Varicella zoster serology
2 2 2 2 2 2
2 2 2 2 2 2
Serum/Plasma Serum/Plasma Serum/Plasma Serum/Plasma Serum/Plasma Serum/Plasma
Viral Program
Alphavirus serology Flavivirus serology Herpes simplex serology Parvovirus serology
2 2 2 2
2 2 2 2
Serum/Plasma Serum/Plasma Serum/Plasma Serum/Plasma
49 | P a g e
Specimen-Free Program
In 2014, three surveys each consisting of two case studies or scenarios will be issued to participants enrolled in the Specimen-free module. This module is not scored and is designed as an educational tool for staff, presenting case studies and scenarios that may be encountered in serological and molecular testing laboratories. Although not scored, report reviewers are encouraged to grade participant responses to the questions posed in the case-study or scenario as satisfactory or unsatisfactory.
Paper Work Only Program

Participants enrolled in the Paperwork-Only module do not receive samples, they receive access to the Final Generic Report library and are able to access and download these reports as required. This module is designed for manufacturers and sponsors (distributors) of kits.
50 | P a g e

Synovial Fluid Discipline
The RCPAQAP Synovial Fluid assesses the ability of laboratories to detect the key disease-related crystals (urate, calcium pyrophosphate) and to differentiate those from other crystalline structures such as corticosteroid, cholesterol and cartilage that may be found in synovial fluid. For detailed information please consult our website. http://www.rcpaqap.com.au/synovial/ Prices for participation are listed in the RCPAQAP myQAP online enrolment customer portal.
Quality Assurance Programs Synovial Fluid Program

Tests - Detection & Identification in Synovial Fluid Surveys /Year Samples /Survey Sample Type
Monosodium Urate Monohydrate (Urate) Crystals Calcium Pyrophosphate Dihydrate (CPPD) Crystals Cholesterol Crystals Synthetic Corticosteroid Crystals Non-crystalline inclusions (cartilage, fibrin, rice bodies) Artefacts (starch, talc) Two surveys, each containing 3 capillary tips per survey are dispatched annually. Participants also receive a DVD/CD of three to five microscopic examinations of synovial fluid to report. A second DVD/CD with the same images, but with a commentary, is sent after the results have been received. 2 3 synovial fluid
51 | P a g e
TISSUE & CELLULAR PATHOLOGY GROUP

Anatomical Pathology Discipline
The RCPAQAP Anatomical Pathology offers modules in the areas of diagnostic and technical proficiency of histopathology laboratories. Diagnostic survey cases are selected to demonstrate either classical histological features of a disease process, common disease processes observed in routine pathology laboratories or critical disease processes of educational value to participants. Technical survey cases are selected on similar criteria of classical, common or critical features to be demonstrated by routine methods in the laboratory. For more details please consult the Anatomical Pathology website. https://anatomical.rcpaqap.com.au/ Prices for participation are listed in the RCPAQAP myQap online enrolment customer portal. The diagnostic proficiency programs offered are for laboratories (collective response) and individual pathologists. Laboratories requiring participation in an external proficiency testing program for Australian accreditation may enrol in the technical and immunohistochemistry programs.
Diagnostic Proficiency Programs

General Module
Tests Surveys/Year Cases/Survey Survey Material
Routine Anatomical Pathology
10
DVD-ROM and available via the website.
Breast Pathology Module

Breast Pathology
10
Oral Pathology Module

Oral Pathology
10
52 | P a g e
Dermatopathology Module
Specialist Dermatopathology
10
Forensic Pathology Module

Specialist Forensic Pathology
10
Gynaecology Module
Specialist Gynaecological Pathology
10
Paediatrics Module
Specialist Paediatric Pathology
10
Urology Module
Specialist Urological Pathology
10
53 | P a g e
Neuropathology Module
Neuropathology
10
HER2 BRISH (Breast) Module

HER-2 BRISH Breast techniques
30
Unstained slides. Formalin fixed paraffin wax sections
HER2 BRISH (Gastric) Module

Tests Surveys/Y ear Cases/Survey Survey Material
HER-2 BRISH Gastric techniques
30
Unstained slides. Formalin fixed paraffin wax sections.
TECHNICAL & TECHNICAL IMMUNOHISTOCHEMISTRY PROGRAMS Technical Module

Routine Anatomical Pathology
1-2
Technical Frozen Module

Frozen sections
Stained section provided by participant
54 | P a g e
Neuropathology Immunohistochemistry & Technical

Neuropathology Immunohistochemistry and Technical
Immunohistochemistry Technical Markers Routine IHC

Routine Immunohistochemistry
Immunohistochemistry Questionnaire Internal Audit

Included with Immunohistochemistry Breast marker Module
Breast marker audit of cases reported by participant
Immunohistochemistry Breast Markers

Breast Immunohistochemistry
Immunohistochemistry Lymphoma Markers

Lymphoma Immunohistochemistry
55 | P a g e
IMMUNOHISTOCHEMISTRY ISH / MOLECULAR PROGRAMS Immunohistochemistry EBV-ISH

EBV-ISH Immunohistochemistry
Immunohistochemistry HPV-ISH
HPV-ISH Immunohistochemistry
COMBINED DIAGNOSTIC & TECHNICAL PROGRAMS
Electron Microscopy
Technical exercise Electron microscopy 1 4 Lab Practice Questionnaire 2 x diagnostic exercises on DVD-ROM and available via the website.
56 | P a g e
TISSUE & CELLULAR PATHOLOGY GROUP

Cytopathology Discipline
The RCPAQAP Cytopathology offers external quality assurance modules that encompass both gynaecological and non-gynaecological Cytopathology practice. Surveys comprise glass slides, DVDs containing virtual cases, staining exercises and questionnaires on laboratory practice. Laboratories may enrol in any or all of the modules. http://www.rcpaqap.com.au/cytopathology/ Prices for participation are listed in the RCPAQAP myQAP online enrolment customer portal.
Quality Assurance Programs Gynaecological Cytopathology

Module Abbrev. Surveys/Year Cases/ Survey Survey Material
Conventional gynaecological Liquid-based ThinPrep gynaecological Liquid-based Surepath gynaecological

Module
GYN THP SUP

Abbrev. Surveys/Year
Conventional cervical smears Liquid- based cervical smears
Survey Material
Performance Measures * * Australian Laboratories Only
PM
Collection of data for NPAAC Performance Measures
Non-gynaecological Cytopathology
Module Abbrev. Surveys/Year Cases/ Survey Survey Material
Non-gynaecological General Non-gynaecological Fine needle Aspiration
GEN FNA
4 4
2 2
One glass slide and one virtual case One glass slide and one virtual case
57 | P a g e
MOLECULAR UNIT
Molecular Genetics Program
The RCPAQAP Molecular Genetics in association with the Human Genetics Society of Australasia provides a range of quality assurance products for an array of inherited disorders and molecular genetics techniques. There is a comprehensive panel of programs on offer from the European Molecular Genetics Quality Network (EMQN), Cystic Fibrosis European Network (CF Network) and the RCPAQAP Molecular Genetics. For further information on the EMQN and CF Network quality assurance programs on offer, please visit their websites: http://www.emqn.org/emqn/Home and http://cf.eqascheme.org/ Prices for participation are listed in the RCPAQAP MyQap online enrolment customer portal.
Quality Assurance Programs Provider - RCPAQAP Molecular Genetics

Module Code Surveys /Year Samples /Survey Survey Material
BRAF mutation screening EGFR mutation screening Fragile X PCR screening KRAS mutation screening Maternal Cell Contamination Mitochondrial Myopathy Sanger DNA sequencing
Module
BRAF EGFR FXPCR KRAS MCC MM DSEQ
2 2 1 2 1 1 1
3 3 5 3 5 5 3
FFPE Tissue FFPE Tissue Purified genomic DNA FFPE Tissue Purified genomic DNA Purified genomic DNA PCR products
Survey Material
Code
Cystic Fibrosis Duchenne & Becker Muscular Dystrophy Fragile X syndrome Hereditary Non-Polyposis Colon Cancer Prader-Willi & Angelman Syndromes Spinal Muscular Atrophy Spinocerebellar Ataxia
CFSUP DMDSUP FXSUP HNPSUP PWASUP SMASUP SCASUP
Supplementary report Supplementary report Supplementary report Supplementary report Supplementary report Supplementary report Supplementary report
58 | P a g e
Provider - Cystic Fibrosis European Network (CF Network)

Cystic Fibrosis
CF
Extracted genomic DNA
Provider - European Molecular Genetics Quality Network (EMQN)

aCGH/Microarray EQA Aicardi-Goutieres Syndrome (pilot) BRAF: Molecular testing in Melanoma Charcot Marie Tooth Disease Congenital Adrenal Hypoplasia Diagnostic Mutation Database DNA-Sequencing EQA scheme Data Assessment only DNA-Sequencing EQA scheme Full version Duchenne & Becker Muscular Dystrophy EGFR: Molecular testing in Lung Cancer (NSCLC) Familial Adenomatous Polyposis Colon Cancer Familial Breast Cancer Full version Familial Breast Cancer Genotyping only Fragile X syndrome Full version Fragile X syndrome Pre-screening Friedrichs Ataxia Hereditary Deafness GJB2/GJB6 Hereditary Haemochromatosis
CGH AGS MELANOMA CMT CAH DMuDB DNAPS DNAF DMD NSCLC FAP BRCA BRCAG FRAX FRAXPS FRDA DFNB1 HFE
2 3 10 3 3 N/A N/A N/A 3 10 3 3 3 3 3 3 3 3
DNA Lyophilised DNA Rolled sections of FFPE materials designed to simulate a real patient sample. Lyophilised DNA Lyophilised DNA N/A Lyophilised and/or wet DNA (in TE) Lyophilised and/or wet DNA (in TE) Lyophilised DNA
Rolled sections of FFPE materials designed to simulate a real patient sample.
Lyophilised DNA Lyophilised DNA Lyophilised DNA DNA in TE Buffer Lyophilised DNA Lyophilised DNA Lyophilised DNA Lyophilised DNA
59 | P a g e
Hereditary Non-Polyposis Colon Cancer Hereditary Recurrent fevers Huntington Disease Monogenic Diabetes Multiple Endocrine Neoplasia Type 2 Myotonic Dystrophy NextGen (2012) pilot EQA scheme Osteogenesis imperfecta Phenylketonuria Porphyria Prader-Willi & Angelman Syndromes Retinoblastoma Short Stature Homeobox Gene Testing Spinal Muscular Atrophy Spinocerebellar Ataxia Von Hippel Lindau Syndrome Wilson disease Y chromosome microdeletions
HNPCC HRF HD MD MEN2 DM NG OI PKU POR PWAS RB SHOX SMA SCA VHL WIL AZF 1
3 4 3 3 3 3 N/A 3 3 3 3 3 3 3 3 3 3 3
Lyophilised DNA Lyophilised DNA Lyophilised DNA Lyophilised DNA Lyophilised DNA Lyophilised DNA Genomic DNA from cell lines Lyophilised and/or wet DNA (in TE) Lyophilised DNA Lyophilised DNA Lyophilised DNA Lyophilised DNA Lyophilised and/or wet DNA (in TE) Lyophilised DNA Lyophilised DNA Lyophilised DNA Lyophilised DNA Lyophilised DNA

Program Module Assays Surveys/ Year Samples/ Survey Sample Type
Factor V Leiden MTHFR (Ala677Val) Prothrombin gene G20210A mutation Hereditary Haemochromatosis Cys282Tyr Module 2 Hereditary Haemochromatosis His63Asp bcr-abl for CML Module 3 bcr-abl for ALL T cell receptor gene Module 4 Immunoglobulin heavy chain gene Module 5 Chimerism Thalassemia beta Module 6 Thalassemia alpha Module 7 Jak 2 Module 8 PML:RARa PLEASE NOTE: bcl-1 / bcl-2 module is no longer available. Module 1
2 2 1 1 1 1 2 1
5 5 5 5 5 3 5 3
DNA DNA RNA DNA DNA DNA DNA RNA
60 | P a g e
VIRTUAL MICROSCOPY UNIT

The RCPA Quality Assurance Programs Pty Limited is committed to providing services to enhance education, training and continuous professional development in pathology. One such service is the use of the Aperio ScanScope to convert glass slides to high resolution digital images and these are now being used for: RCPAQAP Anatomical Pathology diagnostic modules, Some RCPAQAP Cytopathology non-gynaecological surveys, Enhancement of the RCPAQAP Haematology morphology program, Provision of the paediatric morphology program and Provision of the malaria parasite program
For more information please consult the RCPAQAP virtual microscopy unit website or contact us by using the websites contact us form. http://www.rcpaqap.com.au/virtual.microscopy/ The RCPAQAP Virtual Microscopy Unit also offers a scanning service for individuals or organisations. Contact us for an obligation free quote.
RCPAQAP Virtual Microscopy Unit

Phone +61 2 9045 6080 Fax +61 2 9356 2003 Email virtual.microscopy@rcpaqap.com.au
61 | P a g e
NON-ANALYTICAL PROGRAMS UNIT

Key Incident Monitoring & Management Systems (KIMMS)
The Key Incident Monitoring & Management Systems (KIMMS) project was initiated by the Quality Assurance Scientific and Education Committee (QASEC) of the Royal College of Pathologists of Australasia (RCPA). KIMMS aims to monitor the pre- and post-analytical phase of the laboratory quality system and is designed to provide pathology practices with the tools for continuous measurement and monitoring of key incident quality indicators. Please consult the RCPAQAP website for more detailed information on this program. http://www.rcpaqap.com.au/kimms/ Prices for participation are listed in the RCPAQAP myQAP online enrolment customer portal.
Quality Assurance Programs KIMMS Program

Parameters Runs/Year Survey Material
Pre-analytical & post- analytical incidents
Online submission of data
Data collection
Pathology practices are requested to collect data and return to RCPAQAP KIMMS within specified dates. Identification and evaluation of incidents will provide valuable data to each practice to enable measurement, monitoring and improvement of these incidents and ultimately improve patient safety.
Qualified privilege
RCPA Quality Assurance Programs was granted Qualified Privilege from the Department of Health & Ageing, Australia and in New Zealand by the NZ Government
62 | P a g e
POINT-OF-CARE TESTING
The RCPAQAP recognises that PoCT is increasingly being used and that it is essential that the quality of the results generated by a PoCT device is of sufficient quality for patient care. International standards and guidelines recommend that where available, participation in an external quality assurance scheme is recommended for each test. Please refer to the discipline -specific sections in this Catalogue or the discipline-specific Participant Handbooks for more information on these PoCT modules. Alternatively please visit our website: http://www.rcpaqap.com.au/poct/ Prices for participation are listed in the RCPAQAP myQAP online enrolment customer portal.
Chemical Pathology PoCT Chemistry PoCT Troponin PoCT Blood Gases Urine Pregnancy Glycohaemoglobin Lyophilised and Fresh Whole Blood
Serology PoCT HIV PoCT Influenza A & B PoCT RSV Ag Brucella Chlamydia trachomatis Dengue Helicobacter pylori Hepatitis B surface Antigen (HBsAg) Hepatitis C Antibodies (HCV Ab) Hepatitis E lgM (HEV lgM) Hydatid Infectious Mononucleosis Legionella Urinary Antigen Leptospira lgM Syphilis
Haematology PoCT INR Microbiology Urine Dipstick Chemistry Transfusion Snake Venom Detection
63 | P a g e
Quality Assurance Programs Point-of-Care Testing Blood Gases Program

pH pCO2 pO2 Urea
Sodium Potassium Chloride
Glucose Haemoglobin* Lactate
Ionised Calcium Haematocrit* Creatinine
12
Aqueous
*Note: Optimised for the Abbott i-STAT and Alere epoc devices.
Point-of-Care Testing Chemistry Program

Albumin ALP ALT Amylase AST Bicarbonate Bilirubin Total
Bilirubin Conj Calcium Chloride Cholesterol CK Creatinine GGT
Glucose HDL Cholesterol Magnesium LD Phosphate Potassium Protein
Sodium Triglycerides Urate 2 12 Lyophilised Serum and Matching Diluent
Note: This program is designed specifically for PoCT instruments such as the Samsung LABGEO, Roche Reflotron, Abaxis Piccolo, Ortho Clinical Diagnostics DT60, Cholestech Dx etc. Abbott i-STAT are recommended to enrol in the PocT Blood Gases Program.
Point-of-Care Testing Troponin Program

Troponin I Troponin T (semi-quantitative) 2 Note: Suitable for devices such as Abbott i-STAT and Roche cobas h232
12
Serum
64 | P a g e
On-Site Urine Toxicology Screening Program

Amphetamine Methamphetamine Benzodiazepines
Cocaine metabolites Cannabis metabolites Opiates
12
Urine
Urine Pregnancy Program

hCG (qualitative)
Urine
Serology Point-of-Care Program

HIV PoCT ONLY Influenza A & B Antigen PoCT ONLY RSV Antigen PoCT ONLY
2 2 2
4 4 4
Whole blood or Serum/Plasma Inactivated viral culture lysate Inactivated viral culture lysate
Antenatal Program
Syphilis serology
Serum/Plasma
Bacterial Program
Brucella serology Chlamydia trachomatis Antigen EIA Helicobacter pylori serology Legionella Urinary Antigen
2 2 2 2
2 2 2 2
Serum/Plasma Culture supernatant Serum/Plasma Urine
65 | P a g e
Hepatitis Program
Hepatitis B serology Hepatitis C serology Hepatitis E serology
2 2 2
6 6 1
Serum/Plasma Serum/Plasma Serum/Plasma
Infectious Mononucleosis Program

Infectious Mononucleosis
Serum/Plasma
Parasite & Spirochaete Program

Hydatid serology Leptospiral serology
2 2
2 2
Serum/Plasma Serum
Viral Program
Tests Samples/Survey Survey/Year Sample Type
Flavivirus serology (including Dengue)
Serum/Plasma
Point-of-Care INR Program

Tests Surveys/Year Samples/ Survey Sample Type
International Normalised Ratio
Lyophilised plasma + water + calcium
66 | P a g e
Urine Dipstick Chemistry Program

Leukocyte esterase blood glucose protein nitrite
Lyophilised sample
Snake Venom Detection- (SV Program)

Snake Venom Detection
Module Surveys/Year
Samples/Survey
Sample Type
Swab
67 | P a g e
RCPA Quality Assurance Programs Suite 201, Level 2, 8 Herbert Street St Leonards NSW 2065
Phone Fax ABN
+61 2 9045 6000 +61 2 9356 2003 32 003 520 072
www.rcpaqap.com.au
2013 RCPA Quality Assurance Programs Pty Ltd. All rights reserved.

2014 Product Catalogue

Загружено:

Сведения о документе

Авторское право

Доступные форматы

Поделиться этим документом

Поделиться или встроить документ

Параметры публикации

Этот документ был вам полезен?

Это неприемлемый материал?

Авторское право:

Доступные форматы

2014 Product Catalogue

Загружено:

Авторское право:

Доступные форматы

2014 Product Catalogue

RCPA Quality Assurance Programs Pty Ltd ...... 2

2014 Programs ..................................................... 35 Quality Assurance Programs................................. 35

INFECTIOUS DISEASES & IMMUNOLOGY GROUP .......................................................... 42

ENROLMENT OFFICE ........................................ 4

INFECTIOUS DISEASES & IMMUNOLOGY GROUP .......................................................... 46

INFECTIOUS DISEASES & IMMUNOLOGY GROUP .......................................................... 51

CHEMICAL PATHOLOGY GROUP ...................... 7

TISSUE & CELLULAR PATHOLOGY GROUP ..... 52

HAEMATOLOGY & TRANSFUSION GROUP ..... 24

TISSUE & CELLULAR PATHOLOGY GROUP ..... 57

HAEMATOLOGY & TRANSFUSION GROUP ..... 31

MOLECULAR UNIT ......................................... 58

INFECTIOUS DISEASES & IMMUNOLOGY GROUP........................................................... 33

VIRTUAL MICROSCOPY UNIT......................... 61 NON-ANALYTICAL PROGRAMS UNIT............. 62

INFECTIOUS DISEASES & IMMUNOLOGY GROUP........................................................... 35

POINT-OF-CARE TESTING .............................. 63